Revision history of "Phase III research associated with adjuvant gemcitabine compared with adjuvant uraciltegafur in individuals with entirely resected pathological point IBIIIA nonsmall mobile carcinoma of the lung WJTOG0101"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 14:11, 18 April 2024‎ Weightcloudy1 (Talk | contribs)‎ . . (3,225 bytes) (+3,225)‎ . . (Created page with "8%). Individuals together with low BMD had decrease BMI (21.Several (Twenty.2, All day and.0) vs . All day and.0 (Twenty.Several, Twenty six.One particular) Kg/m , p=0.003), l...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Phase_III_research_associated_with_adjuvant_gemcitabine_compared_with_adjuvant_uraciltegafur_in_individuals_with_entirely_resected_pathological_point_IBIIIA_nonsmall_mobile_carcinoma_of_the_lung_WJTOG0101"